Intraperitoneal administration of human “Neo-Islets”, 3-D organoids of mesenchymal stromal and pancreatic islet cells, normalizes blood glucose levels in streptozotocin-diabetic NOD/SCID mice: Significance for clinical trials
Globally, individuals with autoimmune Type 1 diabetes mellitus (T1DM) continue to depend for survival on insulin injections. While pancreas and intrahepatic pancreatic islet transplants can produce insulin-independence and ameliorate serious complications, both therapies depend on potentially toxic...
Guardado en:
Autores principales: | Christof Westenfelder, Zhuma Hu, Ping Zhang, Anna Gooch |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d094cf18efa24e50be75dbcff79e9993 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Intraperitoneal administration of human "Neo-Islets", 3-D organoids of mesenchymal stromal and pancreatic islet cells, normalizes blood glucose levels in streptozotocin-diabetic NOD/SCID mice: Significance for clinical trials.
por: Christof Westenfelder, et al.
Publicado: (2021) -
Lixisenatide accelerates restoration of normoglycemia and improves human beta-cell function and survival in diabetic immunodeficient NOD–scid IL-2rgnull RIP-DTR mice engrafted with human islets
por: Yang C, et al.
Publicado: (2015) - Islets
-
Reevaluation of NOD/SCID Mice as NK Cell-Deficient Models
por: Miao Miao, et al.
Publicado: (2021) -
Insulin-producing organoids engineered from islet and amniotic epithelial cells to treat diabetes
por: Fanny Lebreton, et al.
Publicado: (2019)